BDX Quote, Financials, Valuation and Earnings

Baxter International has a net margin of 5.84% compared to Becton Dickinson &'s net margin of 4.8%. Becton Dickinson &'s return on equity of 5.86% beat Baxter International's return on equity of -7.38%.

Becton Dickinson & has a consensus price target of $216.04, signalling upside risk potential of 21.19%. On the other hand Baxter International has an analysts' consensus of $38.03 which suggests that it could grow by 34.05%. Given that Baxter International has higher upside potential than Becton Dickinson &, analysts believe Baxter International is more attractive than Becton Dickinson &.

Becton Dickinson & has a beta of 0.252, which suggesting that the stock is 74.847% less volatile than S&P 500. In comparison Baxter International has a beta of 0.610, suggesting its less volatile than the S&P 500 by 38.958%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.28%. Baxter International offers a yield of 2.82% to investors and pays a quarterly dividend of $0.17 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Baxter International pays out -90.91% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Baxter International quarterly revenues of $2.6B. Becton Dickinson &'s net income of $308M is higher than Baxter International's net income of $126M. Notably, Becton Dickinson &'s price-to-earnings ratio is 34.02x while Baxter International's PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.48x versus 1.22x for Baxter International. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of 5.84% compared to Becton Dickinson &'s net margin of -5.14%. Becton Dickinson &'s return on equity of 5.86% beat Integer Holdings's return on equity of 4.85%.

Becton Dickinson & has a consensus price target of $216.04, signalling upside risk potential of 21.19%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 27%. Given that Integer Holdings has higher upside potential than Becton Dickinson &, analysts believe Integer Holdings is more attractive than Becton Dickinson &.

Becton Dickinson & has a beta of 0.252, which suggesting that the stock is 74.847% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.988%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.28%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Integer Holdings quarterly revenues of $437.4M. Becton Dickinson &'s net income of $308M is higher than Integer Holdings's net income of -$22.5M. Notably, Becton Dickinson &'s price-to-earnings ratio is 34.02x while Integer Holdings's PE ratio is 55.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.48x versus 2.36x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 5.84% compared to Becton Dickinson &'s net margin of 6.22%. Becton Dickinson &'s return on equity of 5.86% beat Insulet's return on equity of 36.9%.

Becton Dickinson & has a consensus price target of $216.04, signalling upside risk potential of 21.19%. On the other hand Insulet has an analysts' consensus of $336.85 which suggests that it could grow by 16.85%. Given that Becton Dickinson & has higher upside potential than Insulet, analysts believe Becton Dickinson & is more attractive than Insulet.

Becton Dickinson & has a beta of 0.252, which suggesting that the stock is 74.847% less volatile than S&P 500. In comparison Insulet has a beta of 1.346, suggesting its more volatile than the S&P 500 by 34.619%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.28%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Insulet quarterly revenues of $569M. Becton Dickinson &'s net income of $308M is higher than Insulet's net income of $35.4M. Notably, Becton Dickinson &'s price-to-earnings ratio is 34.02x while Insulet's PE ratio is 51.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.48x versus 9.70x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

Tandem Diabetes Care has a net margin of 5.84% compared to Becton Dickinson &'s net margin of -55.69%. Becton Dickinson &'s return on equity of 5.86% beat Tandem Diabetes Care's return on equity of -81.14%.

Becton Dickinson & has a consensus price target of $216.04, signalling upside risk potential of 21.19%. On the other hand Tandem Diabetes Care has an analysts' consensus of $31.70 which suggests that it could grow by 101.27%. Given that Tandem Diabetes Care has higher upside potential than Becton Dickinson &, analysts believe Tandem Diabetes Care is more attractive than Becton Dickinson &.

Becton Dickinson & has a beta of 0.252, which suggesting that the stock is 74.847% less volatile than S&P 500. In comparison Tandem Diabetes Care has a beta of 1.478, suggesting its more volatile than the S&P 500 by 47.763%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.28%. Tandem Diabetes Care offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Tandem Diabetes Care pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Tandem Diabetes Care quarterly revenues of $234.4M. Becton Dickinson &'s net income of $308M is higher than Tandem Diabetes Care's net income of -$130.6M. Notably, Becton Dickinson &'s price-to-earnings ratio is 34.02x while Tandem Diabetes Care's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.48x versus 1.05x for Tandem Diabetes Care. Usually stocks with elevated PS ratios are considered overvalued.